Meeting Banner
Abstract #3106

Magnetic Resonance Imaging for Staging Lymphoma: Whole-Body or Less?

Thomas Kwee1, Erik Akkerman2, Rob Fijnheer3, Marie Jose Kersten4, Joseph Zsiros5, Inge Ludwig6, Marc Bierings7, Jaap Stoker2, Rutger-Jan Nievelstein1

1Department of Radiology, University Medical Center Utrecht, Utrecht, Netherlands; 2Department of Radiology, Academic Medical Center, Amsterdam, Netherlands; 3Department of Hematology, Meander Medical Center, Amersfoort, Netherlands; 4Department of Hematology, Academic Medical Center, Amsterdam, Netherlands; 5Department of Pediatric Oncology, Academic Medical Center, Amsterdam, Netherlands; 6Department of Hematology, University Medical Center Utrecht, Utrecht, Netherlands; 7Department of Pediatric Hematology, University Medical Center Utrecht, Utrecht, Netherlands


Whole-body MRI may be a valuable alternative to (FDG-PET/)CT for staging lymphoma. However, it is unknown whether a whole-body MRI protocol is necessary, or whether an MRI protocol that only has the usual CT coverage (i.e. head/neck and trunk) is comparable while less time-consuming. In this prospective study including 100 consecutive patients with newly diagnosed lymphoma, whole-body MRI did not detect any clinically relevant lesions outside the field of view of an MRI protocol that only includes the head/neck and trunk. Therefore, it may be sufficient to only include the head/neck and trunk when using MRI for staging lymphoma.